Legend Biotech (LEGN) Cash & Current Investments (2019 - 2025)

Legend Biotech has reported Cash & Current Investments for 7 years, with the latest figure at $286.7 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments changed 0.02% year-over-year to $286.7 million; the trailing twelve-month figure through Dec 2025 stood at $286.7 million (changed 0.02% YoY), and the FY2025 full-year result was $286.7 million, changed 0.02% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $286.7 million, up from $278.9 million in the prior quarter.
• The five-year high for Cash & Current Investments was $1.4 billion in Q2 2023, with the low at $243.5 million in Q2 2024.
• Historically, Cash & Current Investments has averaged $649.0 million across 5 years, with a median of $473.7 million in 2021.
• Annual changes were most pronounced in 2021 — Cash & Current Investments soared 485.64% — and 2024, when it sank 82.84%.
• Legend Biotech's Cash & Current Investments stood at $690.4 million in 2021, then soared by 40.74% to $971.6 million in 2022, then jumped by 31.57% to $1.3 billion in 2023, then tumbled by 77.57% to $286.8 million in 2024, then decreased by 0.02% to $286.7 million in 2025.
• The last three Cash & Current Investments figures came in at $286.7 million (Q4 2025), $278.9 million (Q3 2025), and $266.7 million (Q2 2025), per Business Quant data.